Abbott Laboratories (Pakistan) Limited reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was PKR 13,981.91 million compared to PKR 12,271.01 million a year ago. Revenue was PKR 13,981.91 million compared to PKR 12,271.01 million a year ago. Net income was PKR 6.67 million compared to PKR 784.97 million a year ago. Basic earnings per share from continuing operations was PKR 0.07 compared to PKR 8.02 a year ago.
For the nine months, sales was PKR 41,225.09 million compared to PKR 36,951.44 million a year ago. Revenue was PKR 41,225.09 million compared to PKR 36,951.44 million a year ago. Net loss was PKR 792.7 million compared to net income of PKR 2,564.98 million a year ago. Basic loss per share from continuing operations was PKR 8.1 compared to basic earnings per share from continuing operations of PKR 26.2 a year ago.